777 related articles for article (PubMed ID: 16315634)
21. Prevalence and predictors of nonalcoholic steatohepatitis in obese patients undergoing bariatric surgery: a Department of Defense experience.
Reha JL; Lee S; Hofmann LJ
Am Surg; 2014 Jun; 80(6):595-9. PubMed ID: 24887798
[TBL] [Abstract][Full Text] [Related]
22. Apoptosis is associated with CD36/fatty acid translocase upregulation in non-alcoholic steatohepatitis.
Bechmann LP; Gieseler RK; Sowa JP; Kahraman A; Erhard J; Wedemeyer I; Emons B; Jochum C; Feldkamp T; Gerken G; Canbay A
Liver Int; 2010 Jul; 30(6):850-9. PubMed ID: 20408954
[TBL] [Abstract][Full Text] [Related]
23. Serum proteomic profiling of obese patients: correlation with liver pathology and evolution after bariatric surgery.
Trak-Smayra V; Dargere D; Noun R; Albuquerque M; Yaghi C; Gannagé-Yared MH; Bedossa P; Paradis V
Gut; 2009 Jun; 58(6):825-32. PubMed ID: 18403495
[TBL] [Abstract][Full Text] [Related]
24. [Non alcoholic steatohepatitis].
Manero E; Findor JA; Avagnina A; de Elizalde S; Elsner B
Medicina (B Aires); 1994; 54(6):625-9. PubMed ID: 7658998
[TBL] [Abstract][Full Text] [Related]
25. Liver damage in severely obese patients: a clinical-biochemical-morphologic study on 1,000 liver biopsies.
Papadia FS; Marinari GM; Camerini G; Murelli F; Carlini F; Stabilini C; Scopinaro N
Obes Surg; 2004 Aug; 14(7):952-8. PubMed ID: 15329185
[TBL] [Abstract][Full Text] [Related]
26. Apnoeic-hypopnoeic episodes during obstructive sleep apnoea are associated with histological nonalcoholic steatohepatitis.
Mishra P; Nugent C; Afendy A; Bai C; Bhatia P; Afendy M; Fang Y; Elariny H; Goodman Z; Younossi ZM
Liver Int; 2008 Sep; 28(8):1080-6. PubMed ID: 18647236
[TBL] [Abstract][Full Text] [Related]
27. Visceral adipose tissue and inflammation correlate with elevated liver tests in a cohort of overweight and obese patients.
Verrijken A; Francque S; Mertens I; Talloen M; Peiffer F; Van Gaal L
Int J Obes (Lond); 2010 May; 34(5):899-907. PubMed ID: 20142825
[TBL] [Abstract][Full Text] [Related]
28. Serologic predictors of nonalcoholic steatohepatitis in a population undergoing bariatric surgery.
Chisholm J; Seki Y; Toouli J; Stahl J; Collins J; Kow L
Surg Obes Relat Dis; 2012; 8(4):416-22. PubMed ID: 21865094
[TBL] [Abstract][Full Text] [Related]
29. Prospective study of the long-term effects of bariatric surgery on liver injury in patients without advanced disease.
Mathurin P; Hollebecque A; Arnalsteen L; Buob D; Leteurtre E; Caiazzo R; Pigeyre M; Verkindt H; Dharancy S; Louvet A; Romon M; Pattou F
Gastroenterology; 2009 Aug; 137(2):532-40. PubMed ID: 19409898
[TBL] [Abstract][Full Text] [Related]
30. Predictors of nonalcoholic steatohepatitis (NASH) in obese patients undergoing gastric bypass.
Boza C; Riquelme A; Ibañez L; Duarte I; Norero E; Viviani P; Soza A; Fernandez JI; Raddatz A; Guzman S; Arrese M
Obes Surg; 2005 Sep; 15(8):1148-53. PubMed ID: 16197788
[TBL] [Abstract][Full Text] [Related]
31. Obesity-related non-alcoholic steatohepatitis and TGF-beta1 serum levels in relation to morbid obesity.
Sepúlveda-Flores RN; Vera-Cabrera L; Flores-Gutiérrez JP; Maldonado-Garza H; Salinas-Garza R; Zorrilla-Blanco P; Bosques-Padilla FJ
Ann Hepatol; 2002; 1(1):36-9. PubMed ID: 15114294
[TBL] [Abstract][Full Text] [Related]
32. Effect of exercise and dietary modification on serum aminotransferase levels in patients with nonalcoholic steatohepatitis.
Sreenivasa Baba C; Alexander G; Kalyani B; Pandey R; Rastogi S; Pandey A; Choudhuri G
J Gastroenterol Hepatol; 2006 Jan; 21(1 Pt 1):191-8. PubMed ID: 16706832
[TBL] [Abstract][Full Text] [Related]
33. Prevalence and predictors of asymptomatic liver disease in patients undergoing gastric bypass surgery.
Beymer C; Kowdley KV; Larson A; Edmonson P; Dellinger EP; Flum DR
Arch Surg; 2003 Nov; 138(11):1240-4. PubMed ID: 14609874
[TBL] [Abstract][Full Text] [Related]
34. Risk factors associated with nonalcoholic fatty liver disease and its relationship with the hepatic histological changes.
Rodríguez-Hernández H; Gonzalez JL; Márquez-Ramirez MD; Flores-Hernandez M; Rodríguez-Morán M; Guerrero-Romero F
Eur J Gastroenterol Hepatol; 2008 May; 20(5):399-403. PubMed ID: 18403941
[TBL] [Abstract][Full Text] [Related]
35. Independent predictors of liver fibrosis in patients with nonalcoholic steatohepatitis.
Angulo P; Keach JC; Batts KP; Lindor KD
Hepatology; 1999 Dec; 30(6):1356-62. PubMed ID: 10573511
[TBL] [Abstract][Full Text] [Related]
36. Aminotransferase activity in morbid and uncomplicated obesity: predictive role of fasting insulin.
Iacobellis G; Moschetta A; Buzzetti R; Ribaudo MC; Baroni MG; Leonetti F
Nutr Metab Cardiovasc Dis; 2007 Jul; 17(6):442-7. PubMed ID: 17134955
[TBL] [Abstract][Full Text] [Related]
37. Histopathological algorithm and scoring system for evaluation of liver lesions in morbidly obese patients.
Bedossa P; Poitou C; Veyrie N; Bouillot JL; Basdevant A; Paradis V; Tordjman J; Clement K
Hepatology; 2012 Nov; 56(5):1751-9. PubMed ID: 22707395
[TBL] [Abstract][Full Text] [Related]
38. Factors associated with the presence of nonalcoholic steatohepatitis in patients with chronic hepatitis C.
Solis-Herruzo JA; Pérez-Carreras M; Rivas E; Fernández-Vázquez I; Garfia C; Bernardos E; Castellano G; Colina F
Am J Gastroenterol; 2005 May; 100(5):1091-8. PubMed ID: 15842583
[TBL] [Abstract][Full Text] [Related]
39. Prevalence and predictive factors of non-alcoholic steatohepatitis (NASH) in morbidly obese patients undergoing bariatric surgery.
Harnois F; Msika S; Sabaté JM; Mechler C; Jouet P; Barge J; Coffin B
Obes Surg; 2006 Feb; 16(2):183-8. PubMed ID: 16469221
[TBL] [Abstract][Full Text] [Related]
40. Ursodeoxycholic acid or clofibrate in the treatment of non-alcohol-induced steatohepatitis: a pilot study.
Laurin J; Lindor KD; Crippin JS; Gossard A; Gores GJ; Ludwig J; Rakela J; McGill DB
Hepatology; 1996 Jun; 23(6):1464-7. PubMed ID: 8675165
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]